Biotechnology - a key discipline in the north
In northern Germany, biotechnology has developed into a central driver of medical innovation. In March 2026, an article was published featuring Indivumed as an example of how deep molecular profiling, high-quality samples and functional models support modern oncology R&D.
)
The future of biotechnology in northern Germany
What happens when collaboration between academia and industry meets growing investment in clinical development, personalized medicine and biotech manufacturing?
In northern Germany, it has led to a thriving life sciences innovation network, and we're proud that Indivumed is part of it. In LSN's latest article, we share our perspective on how this ecosystem is shaping the future of biotechnology in the region.
Our founder and CEO, Prof. Dr. Hartmut Juhl, emphasizes the importance of high-quality patient data, close collaboration between science and industry, and true biological insight as the basis for successful precision medicine: “By integrating multi-omics data, comparing tumor and normal tissue from our biobank, and enriching relevant clinical patient data, we identify specific molecular changes and new therapeutic targets that would not be visible genomically alone.”
We are happy to share the article published online on LSN's website.